Course of Depression and Anxiety Diagnosis in Patients Treated with Hemodialysis: A 16-month Follow-up
Course of Depression and Anxiety Diagnosis in Patients Treated with Hemodialysis: A 16-month Follow-up
复制标题
DOI:
10.2215/cjn.01120308
复制
发表时间:
2008-11-01
影响因子:
9.8
通讯作者:
Kimmel, Paul L.
中科院分区:
文献类型:
--
作者:
Cukor, Daniel;Coplan, Jeremy;Kimmel, Paul L.
Background and objectives: There is growing identification of the need to seriously study the psychiatric presentations of end-stage renal disease patients treated with hemodialysis. This study reports on the course of depression and anxiety diagnoses and their impact on quality of life and health status.Design, setting, participants, & measurements: The 16-mo course of psychiatric diagnoses in 50 end-stage renal disease patients treated with hemodialysis was measured by structured clinical interview.Results: Three different pathways were identified: one subset of patients not having a psychiatric diagnosis at either baseline or 16-mo follow-up (68% for depression, 51% for anxiety), one group having an intermittent course (21% for depression, 34o% for anxiety), and one group having a persistent course (11% for depression, 15% for anxiety), with diagnoses at both time I and time 2. For depression, the people with the persistent course showed marked decreases in quality of life and self-reported health status compared with the nondepressed and intermittently depressed cohorts. The most powerful predictor of depression at time 2 is degree of depressive affect at time 1(P < 0.05).Conclusions: Patients at risk for short- and long-term complications of depression can be potentially identified by high levels of depressive affect even at a single time point. As nearly 20% of the sample had chronic depression or anxiety, identifying a psychiatric diagnosis in hemodialysis patients and then offering treatment are important because, in the absence of intervention, psychiatric disorders are likely to persist in a substantial proportion of patients.